Ignite Creation Date:
2024-05-05 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00501241
Status:
TERMINATED
Last Update Posted:
2009-06-17
First Post:
2007-07-12
Brief Title:
Phase II Randomized Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation
Sponsor:
Procter and Gamble
Organization:
Procter and Gamble
Study Overview
Official Title:
A Phase II Randomized Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation
Status:
TERMINATED
Status Verified Date:
2008-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether ATI-7505 is effective in the treatment of chronic idiopathic constipation
Detailed Description:
This study is designed to evaluate the safety and efficacy of ATI 7505 in generally healthy adult patients who have had symptoms of chronic idiopathic constipation for at least 6 months as defined in the ROME III criteria
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None